ValiRx plc (AIM:VAL)
London · Delayed Price · Currency is GBP · Price in GBX 0.3250
+0.0100 (3.17%)
At close: Mar 4, 2026
ValiRx Revenue
ValiRx had revenue of 49.78K GBP in the twelve months ending June 30, 2025, up 418.49% year-over-year. In the year 2024, ValiRx had annual revenue of 49.78K with 418.49% growth.
Revenue
49.78K
Revenue Growth
+418.49%
P/S Ratio
48.50
Revenue / Employee
3.56K
Employees
14
Market Cap
2.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49.78K | 40.18K | 418.49% |
| Dec 31, 2023 | 9.60K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Futura Medical | 7.93M |
| IXICO | 6.53M |
| OptiBiotix Health | 1.15M |
| Oxford BioDynamics | 1.10M |
| Physiomics | 1.01M |
| CRISM Therapeutics | 25.00K |
ValiRx News
- 4 months ago - AIM Market Roundup: Haydale Graphene, Marechale Capital, Getech - The Armchair Trader
- 1 year ago - Small Cap Stocks: Catenai, Genip, ValiRx - The Armchair Trader
- 1 year ago - Small Cap Stocks: Guardian Metal, MediaZest, Enwell - The Armchair Trader
- 1 year ago - Small Cap Stocks: Valirx, EnergyPathways, Merit Group - The Armchair Trader